RELITECT

relitect-logo

Relitect is developing a novel assay platform for the label free electrochemical detection of binding events. The company's proprietary technology can be applied for high sensitivity, multiplexed diagnostic and life science research products.

#SimilarOrganizations #People #Financial #Website #More

RELITECT

Industry:
Biotechnology Health Diagnostics

Founded:
2014-01-01

Address:
Glasgow, Glasgow City, United Kingdom

Country:
United Kingdom

Website Url:
http://www.relitect.com

Total Employee:
11+

Status:
Closed

Total Funding:
750 K GBP

Technology used in webpage:
OpenResty Encryption Everywhere DNS.COM Sharktech Shark Tech


Similar Organizations

applied-proteomics-logo

Applied Proteomics

Applied Proteomics offers a protein biomarker discovery platform to advance the application of proteomics.

clinical-genomics-technologies-logo

Clinical Genomics Technologies

Clinical Genomics develops innovative products for colorectal cancer diagnosis.

molecular-health-logo

Molecular Health

Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.

Current Employees Featured

not_available_image

Giles Davies
Giles Davies Founder @ Relitect
Founder

not_available_image

Christoph Walti
Christoph Walti Founder @ Relitect
Founder

Founder


not_available_image

Christoph Walti

not_available_image

Giles Davies

Investors List

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Seed Round - Relitect

ip-group-plc_image

IP Group

IP Group investment in Seed Round - Relitect

Official Site Inspections

http://www.relitect.com

Unable to get host informations!!!

Loading ...

More informations about "Relitect"

Relitect - Crunchbase Company Profile & Funding

Relitect is developing a novel assay platform for the label free electrochemical detection of binding events. The company's proprietary technology can be applied for high sensitivity, multiplexed โ€ฆSee details»

Relitect - VentureRadar

Website: http://www.relitect.com/ Relitect are developing a novel technology for the detection of binding events, which can be used for the analysis of proteins, small molecules and nucleic acids.See details»

Relitect Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Relitect. Use the PitchBook Platform to explore the full profile.See details»

Relitect Company Profile | Management and Employees List

Find contact information for Relitect. Learn about their Medical Devices & Equipment, Manufacturing market share, competitors, and Relitect's email format.See details»

Relitect Ltd โ€“ Developing Next Generation Bioassays

Jun 9, 2015ย ยท Relitect Ltd, a new University of Leeds spin out and IKC partner, and developer of a novel bioassay platform has secured an investment of ยฃ750K. The Relitect proprietary โ€ฆSee details»

Relitect - Company Profile - Tracxn

Nov 14, 2024ย ยท Relitect develops solutions for the label-free detection of biomolecules. Its proprietary platform uses an array of gold electrodes that are coated with polymers conjugated โ€ฆSee details»

Relitect - Funding, Financials, Valuation & Investors - Crunchbase

Relitect is developing a novel assay platform for the label free electrochemical detection of binding events.See details»

Relitect - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Relitect is developing a novel assay platform for the label free electrochemical detection of binding events.See details»

Relitect - Products, Competitors, Financials, Employees, โ€ฆ

Relitect, founded in 2014 is out of business. It develops a diagnostic technology for the detection of binding events, that can be used for the analysis of proteins, small molecules, and nucleic โ€ฆSee details»

Relitect | VentureRadar

Website: http://www.relitect.com/ Relitect are developing a novel technology for the detection of binding events, which can be used for the analysis of proteins, small molecules and nucleic acids.See details»

Relitect moves to BioCity Scotland after securing ยฃ750K of โ€ฆ

Life sciences company Relitect Ltd has become the latest new tenant at BioCity Scotland, an incubator in Lanarkshire which houses and supports growing life sciences organisations.See details»

What is Relitect? Company Culture, Mission, Values

See what employees say it's like to work at Relitect. Salaries, reviews, and more - all posted by employees working at Relitect.See details»

Relitect - Crunchbase

Relitect is developing a novel assay platform for the label free electrochemical detection of binding events.See details»

Working at Relitect - Glassdoor

Glassdoor gives you an inside look at what it's like to work at Relitect, including salaries, reviews, office photos, and more. This is the Relitect company profile. All content is posted โ€ฆSee details»

Relitect Reviews: What Is It Like to Work At Relitect?

1 Relitect reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»

Working at Relitect - Glassdoor

See what employees say it's like to work at Relitect. Salaries, reviews, and more - all posted by employees working at Relitect.See details»

Relitect - Contacts, Employees, Board Members, Advisors & Alumni

Relitect is developing a novel assay platform for the label free electrochemical detection of binding events.See details»

Scottish Enterprise details ยฃ4.6 million worth of failed investments

Aug 31, 2021ย ยท Scottish Enterprise also invested ยฃ949,000 into Relitect, a spin-out from Leeds University which wanted to commercialise high sensitivity impedance spectroscopy technology.See details»

Twin Galaxies - Wikipedia

In mid-1981, Walter Day, founder of Twin Galaxies, Inc., visited more than 100 video game arcades over four months, recording the high scores that he found on each game. [citation โ€ฆSee details»

Giles Davies - Founder @ Relitect - Crunchbase Person Profile

Giles Davies is the founder of Relitect.See details»

linkstock.net © 2022. All rights reserved